Alisertib is an orally available small molecule that functions as a highly selective inhibitor of aurora A kinase, an enzyme often overexpressed in various malignancies. This antineoplastic agent is primarily… Read more
Alisertib is an orally available small molecule that functions as a highly selective inhibitor of aurora A kinase, an enzyme often overexpressed in various malignancies. This antineoplastic agent is primarily investigated for its therapeutic potential in treating solid tumors, including ovarian cancer and other aggressive cancers. Laboratories rely on high-quality reference standards of Alisertib to support rigorous analytical testing, including impurity profiling and method validation. The category includes the parent drug API alongside essential related compounds such as process-related impurities, degradation products identified during stability testing, and stable isotope-labelled standards. These labelled compounds are critical tools for researchers conducting quantitative analysis, particularly when using liquid chromatography-mass spectrometry to ensure accuracy and reproducibility in quality control workflows. By utilizing these precise materials, analytical chemists can effectively monitor compound identity, purity, and concentration throughout the pharmaceutical development lifecycle.